PharmAthene (PIP) Issues Encouraging Update on Recombant Protective Antigen Formulated with DepoVax

February 2, 2015 10:24 AM EST Send to a Friend
PharmAthene (AMEX: PIP) announced that its recombinant Protective Antigen (rPA) was one of the vaccines reported by Immunovaccine, Inc., to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login